Skip to content

Saturday, July 5, 2025

Latest:

Surviving cancer and tracheoesophageal fistula: Sandy Tovey’s journey
Handy ‘MasSpec Pen’ collection could help detect opioids from the skin
A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Akt pathway

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021 Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

CD44s, not CD44v, contributes to cancer survival

July 25, 2017 Akt pathway, alternative splicing, cancer survival, CD44, EGFR signaling

Cells may stray away from their normal function in a number of ways. For example, it’s been known for some time that in a number

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951